Antitumor properties of histamine in vivo

Nature Medicine

Volumn 17, Issue 5, 2011, Pages 537-

  Thoren, Fredrik B ^a,b   Aurelius, Johan ^b   Martner, Anna ^b  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

HISTAMINE; HISTIDINE DECARBOXYLASE; INTERLEUKIN 2;

ACUTE GRANULOCYTIC LEUKEMIA; ANTINEOPLASTIC ACTIVITY; ASCITIC CARCINOMA; BONE MARROW CELL; CANCER CHEMOTHERAPY; CANCER IMMUNOTHERAPY; CANCER SURVIVAL; CANCER SUSCEPTIBILITY; CARCINOMA CELL; CELL DIFFERENTIATION; COLORECTAL CARCINOMA; CYTOTOXIC LYMPHOCYTE; DRUG EFFECT; DRUG MECHANISM; EUROPE; FIBROSARCOMA; HUMAN; IN VIVO STUDY; INTESTINE ADENOCARCINOMA; ISRAEL; KIDNEY CARCINOMA; LETTER; LEUKEMIA RELAPSE; LYMPHOMA; LYMPHOMA CELL; MACROPHAGE; MELANOMA; NONHUMAN; PRIORITY JOURNAL; SARCOMA CELL;

ANIMALS; ANTINEOPLASTIC AGENTS; HISTAMINE; HUMANS; LEUKEMIA, MYELOID, ACUTE; MICE; MYELOID CELLS; NEOPLASTIC STEM CELLS;

EID: 79955692745     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm0511-537a     Document Type: Letter

References (10)

1. Yang, X.D. et al. Nat. Med. 17, 87-95 (2011).
2. Gabrilovich, D.I. & Nagaraj, S. Nat. Rev. Immunol. 9, 162-174 (2009).
3. Burtin, C., Scheinmann, P., Salomon, J.C., Lespinats, G. & Canu, P. Br. J. Cancer 45, 54-60 (1982).
4. della Rovere, F., Broccio, G., Granata, A. & Fimiani, V. Oncol. Rep. 1, 175-177 (1994).
5. Suonio, E., Tuomisto, L. & Alhava, E. Agents Actions 41 Spec No, C118-C120 (1994).
6. Tatsuta, M. et al. J. Natl. Cancer Inst. 76, 277-281 (1986).
7. Hellstrand, K. Semin. Oncol. 29, 35-40 (2002).
8. Martner, A. et al. Expert Rev. Hematol. 3, 381-391 (2010).
9. Donskov, F., Hokland, M., Marcussen, N., Torp Madsen, H.H. & von der Maase, H. Br. J. Cancer 94, 218-226 (2006).
10. Brune, M. et al. Blood 108, 88-96 (2006).